BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11073990)

  • 1. A novel Rb- and p300-binding protein inhibits transactivation by MyoD.
    MacLellan WR; Xiao G; Abdellatif M; Schneider MD
    Mol Cell Biol; 2000 Dec; 20(23):8903-15. PubMed ID: 11073990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EID-2, a novel member of the EID family of p300-binding proteins inhibits transactivation by MyoD.
    Ji A; Dao D; Chen J; MacLellan WR
    Gene; 2003 Oct; 318():35-43. PubMed ID: 14585496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle.
    Miyake S; Sellers WR; Safran M; Li X; Zhao W; Grossman SR; Gan J; DeCaprio JA; Adams PD; Kaelin WG
    Mol Cell Biol; 2000 Dec; 20(23):8889-902. PubMed ID: 11073989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
    Sandmöller A; Meents H; Arnold HH
    Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway.
    Magenta A; Cenciarelli C; De Santa F; Fuschi P; Martelli F; Caruso M; Felsani A
    Mol Cell Biol; 2003 Apr; 23(8):2893-906. PubMed ID: 12665587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD.
    Bailey P; Sartorelli V; Hamamori Y; Muscat GE
    Nucleic Acids Res; 1998 Dec; 26(23):5501-10. PubMed ID: 9826778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.
    Cenciarelli C; De Santa F; Puri PL; Mattei E; Ricci L; Bucci F; Felsani A; Caruso M
    Mol Cell Biol; 1999 Jul; 19(7):5203-17. PubMed ID: 10373569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
    Sartorelli V; Huang J; Hamamori Y; Kedes L
    Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREB-binding protein/p300 activates MyoD by acetylation.
    Polesskaya A; Duquet A; Naguibneva I; Weise C; Vervisch A; Bengal E; Hucho F; Robin P; Harel-Bellan A
    J Biol Chem; 2000 Nov; 275(44):34359-64. PubMed ID: 10944526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ablation of retinoblastoma protein function by the RET finger protein.
    Krützfeldt M; Ellis M; Weekes DB; Bull JJ; Eilers M; Vivanco MD; Sellers WR; Mittnacht S
    Mol Cell; 2005 Apr; 18(2):213-24. PubMed ID: 15837424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
    Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
    EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-mediated regulation of smooth muscle alpha-actin gene transcription in fibroblasts and vascular smooth muscle cells involves multiple adenovirus E1A-interacting cofactors.
    Wang SX; Elder PK; Zheng Y; Strauch AR; Kelm RJ
    J Biol Chem; 2005 Feb; 280(7):6204-14. PubMed ID: 15576380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of differentiation by HBP1, a target of the retinoblastoma protein.
    Shih HH; Tevosian SG; Yee AS
    Mol Cell Biol; 1998 Aug; 18(8):4732-43. PubMed ID: 9671483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
    Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
    Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
    J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.
    Puri PL; Sartorelli V; Yang XJ; Hamamori Y; Ogryzko VV; Howard BH; Kedes L; Wang JY; Graessmann A; Nakatani Y; Levrero M
    Mol Cell; 1997 Dec; 1(1):35-45. PubMed ID: 9659901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a dominant negative retinoblastoma protein (RB) inhibiting satellite myoblast differentiation implies an indirect interaction between MyoD and RB.
    Li FQ; Coonrod A; Horwitz M
    Mol Cell Biol; 2000 Jul; 20(14):5129-39. PubMed ID: 10866669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.